Celera Corporation - Product Pipeline Analysis, 2015 Update

Date: April 8, 2015
Pages: 33
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C1287F45ED5EN
Leaflet:

Download PDF Leaflet

Celera Corporation - Product Pipeline Analysis, 2015 Update
SUMMARY

Celera Corporation (Celera) a subsidiary of Quest Diagnostics Inc is a pharmaceutical company that develops, manufactures, and commercializes molecular diagnostic products. The company offers products such as infectious diseases products, genetics and proteomics, transplantation products, systems and reagents for laboratory developed tests. It provides disease management tools and services. Celera conducts various research and development programs to develop its product base. The company’s products are used by hospitals and other clinical laboratories to detect, characterize, monitor and select treatment for diseases. Celera is headquartered in Alameda, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

SCOPE:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Celera Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
REASONS TO BUY:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Celera Corporation Company Snapshot
Celera Corporation Company Overview
Key Information
Celera Corporation Pipeline Products and Clinical Trials Overview
Celera Corporation – Pipeline Analysis Overview
Key Facts
Celera Corporation - Major Products and Services
Celera Corporation Pipeline Products by Development Stage
Celera Corporation Pipeline Products Overview
Celera Thrombophilia Genotyping Assay
Celera Thrombophilia Genotyping Assay Product Overview
Chimerism Assay - Transplant Rejection
Chimerism Assay - Transplant Rejection Product Overview
Fragile - X Genotyping Assay
Fragile - X Genotyping Assay Product Overview
KIF6 Test - Coronary Heart Disease
KIF6 Test - Coronary Heart Disease Product Overview
Liver Fibrosis Genotyping Assay
Liver Fibrosis Genotyping Assay Product Overview
Lung Cancer Genotyping Assay
Lung Cancer Genotyping Assay Product Overview
ViroSeq HBV Assay
ViroSeq HBV Assay Product Overview
ViroSeq HCV Assay
ViroSeq HCV Assay Product Overview
ViroSeq HIV Integrase Assay
ViroSeq HIV Integrase Assay Product Overview
Celera Corporation - Key Competitors
Celera Corporation - Key Employees
Celera Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Celera Corporation, Recent Developments
Apr 20, 2011: Celera Provides Update On Recent Scientific Findings On KIF6 And PMA Application For KIF6 Genotyping Assay
Apr 18, 2011: Celera Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition By Quest Diagnostics
Jan 03, 2011: Celera Submits Premarket Approval Application For KIF6 Genotyping Assay
Dec 20, 2010: Celera Appoints Alfred Merriweather As Senior Vice President, CFO
Aug 25, 2010: Celera Announces Issuance Of US Patent Relating To LPA Gene Variant Related To Increased Risk For Myocardial Infarction
Aug 03, 2010: Celera Reports Net Revenues Of $32.6 Million In Q2 2010
Jun 07, 2010: Celera Announces CE Mark Filing For KIF6 Test
Mar 03, 2010: Celera Reports Net Revenues Of $167.1 Million In 2009
Aug 06, 2009: Celera Reports Net Revenues Of $41.4 Million In Q2 2009
Jul 22, 2009: Celera Reports Q2 2009 Preliminary Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Celera Corporation, Key Facts
Celera Corporation Pipeline Products and Clinical Trials Overview
Celera Corporation Pipeline Products by Equipment Type
Celera Corporation Pipeline Products by Indication
Celera Corporation, Key Facts
Celera Corporation, Major Products and Services
Celera Corporation Number of Pipeline Products by Development Stage
Celera Corporation Pipeline Products Summary by Development Stage
Celera Thrombophilia Genotyping Assay - Product Status
Celera Thrombophilia Genotyping Assay - Product Description
Chimerism Assay - Transplant Rejection - Product Status
Chimerism Assay - Transplant Rejection - Product Description
Fragile - X Genotyping Assay - Product Status
Fragile - X Genotyping Assay - Product Description
KIF6 Test - Coronary Heart Disease - Product Status
KIF6 Test - Coronary Heart Disease - Product Description
Liver Fibrosis Genotyping Assay - Product Status
Liver Fibrosis Genotyping Assay - Product Description
Lung Cancer Genotyping Assay - Product Status
Lung Cancer Genotyping Assay - Product Description
ViroSeq HBV Assay - Product Status
ViroSeq HBV Assay - Product Description
ViroSeq HCV Assay - Product Status
ViroSeq HCV Assay - Product Description
ViroSeq HIV Integrase Assay - Product Status
ViroSeq HIV Integrase Assay - Product Description
Celera Corporation, Key Employees
Celera Corporation, Other Locations
Celera Corporation, Subsidiaries

LIST OF FIGURES

Celera Corporation Pipeline Products by Equipment Type
Celera Corporation Pipeline Products by Development Stage
Skip to top


Ask Your Question

Celera Corporation - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: